Vaccination against yellow fever in rheumatic diseases
Yellow fever (YF) is an obligate, transmissible, feral herd infectious disease characterized by multiple organ dysfunction and high mortality rates. The intensification of international relations and tourist flows, including those to the YF endemic areas in recent years has substantially increased t...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2019-10-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/966 |
id |
doaj-e3c28cccfd474ef59cec07102027750f |
---|---|
record_format |
Article |
spelling |
doaj-e3c28cccfd474ef59cec07102027750f2021-07-29T09:00:13ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2019-10-011349910310.14412/1996-7012-2019-4-99-1032218Vaccination against yellow fever in rheumatic diseasesB. S. Belov0G. M. Tarasova1N. V. Muravyeva2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyYellow fever (YF) is an obligate, transmissible, feral herd infectious disease characterized by multiple organ dysfunction and high mortality rates. The intensification of international relations and tourist flows, including those to the YF endemic areas in recent years has substantially increased the value of vaccination against this infection in patients on immunosuppressive therapy for immunological disorders, including rheumatic diseases (RDs). In this connection, the recently published guidelines by the experts of the Brazilian Society of Rheumatology on the efficiency and safety of immunization against YL in patients with chronic immune-mediated inflammatory diseases (including RDs) are of great interest. The main provisions of these guidelines are presented in this paper.https://mrj.ima-press.net/mrj/article/view/966yellow fevervaccinationrheumatic diseases |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
B. S. Belov G. M. Tarasova N. V. Muravyeva |
spellingShingle |
B. S. Belov G. M. Tarasova N. V. Muravyeva Vaccination against yellow fever in rheumatic diseases Современная ревматология yellow fever vaccination rheumatic diseases |
author_facet |
B. S. Belov G. M. Tarasova N. V. Muravyeva |
author_sort |
B. S. Belov |
title |
Vaccination against yellow fever in rheumatic diseases |
title_short |
Vaccination against yellow fever in rheumatic diseases |
title_full |
Vaccination against yellow fever in rheumatic diseases |
title_fullStr |
Vaccination against yellow fever in rheumatic diseases |
title_full_unstemmed |
Vaccination against yellow fever in rheumatic diseases |
title_sort |
vaccination against yellow fever in rheumatic diseases |
publisher |
IMA-PRESS LLC |
series |
Современная ревматология |
issn |
1996-7012 2310-158X |
publishDate |
2019-10-01 |
description |
Yellow fever (YF) is an obligate, transmissible, feral herd infectious disease characterized by multiple organ dysfunction and high mortality rates. The intensification of international relations and tourist flows, including those to the YF endemic areas in recent years has substantially increased the value of vaccination against this infection in patients on immunosuppressive therapy for immunological disorders, including rheumatic diseases (RDs). In this connection, the recently published guidelines by the experts of the Brazilian Society of Rheumatology on the efficiency and safety of immunization against YL in patients with chronic immune-mediated inflammatory diseases (including RDs) are of great interest. The main provisions of these guidelines are presented in this paper. |
topic |
yellow fever vaccination rheumatic diseases |
url |
https://mrj.ima-press.net/mrj/article/view/966 |
work_keys_str_mv |
AT bsbelov vaccinationagainstyellowfeverinrheumaticdiseases AT gmtarasova vaccinationagainstyellowfeverinrheumaticdiseases AT nvmuravyeva vaccinationagainstyellowfeverinrheumaticdiseases |
_version_ |
1721250215665598464 |